<!doctype html><html lang=en><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Hugo 0.55.0"><meta name=author content="Clemens Ager"><meta name=description content="Number Cruncher // PhD Candidate // Physicist"><script defer src=https://use.fontawesome.com/releases/v5.0.13/js/all.js integrity=sha384-xymdQtn1n3lH2wcu0qhcdaOpQwyoarkgLVxC/wZ5q7h9gHtxICrpcaSUfygqZGOe crossorigin=anonymous></script><link href="https://fonts.googleapis.com/css?family=Montserrat|Raleway:100,400" rel=stylesheet><link rel=stylesheet href=https://bdcaf.github.io/style.min.f55e2bec4a26016f7b2eb2fb0e3c6116a40ad267b2993cefe0d4bb0c1a6e145c3c1e2b653c7da7704a629522ad714e4e2aa0659d096a22f0d61a58ebd8971707.css integrity="sha512-9V4r7EomAW97LrL7DjxhFqQK0meymTzv4NS7DBpuFFw8HitlPH2ncEpilSKtcU5OKqBlnQlqIvDWGljr2JcXBw=="><link rel=alternate href=https://bdcaf.github.io/tags/index.xml type=application/rss+xml title="C. Ager"><link rel=feed href=https://bdcaf.github.io/tags/index.xml type=application/rss+xml title="C. Ager"><link rel=canonical href=https://bdcaf.github.io/publication/filipiak2012a/><title>Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.|C. Ager</title></head><body id=top><header><h1 class=logo><a href=https://bdcaf.github.io/>clemens<b>ager</b></a></h1><div class=container><a href=#main-menu role=button id=main-menu-toggle class=menu-toggle aria-expanded=false aria-controls=main-menu aria-label="Open main menu"><span class=sr-only>Open main menu</span>
<span aria-hidden=true><i class="fas fa-bars"></i></span></a><nav id=main-menu role=navigation class=main-menu aria-expanded=false aria-label="Main menu"><a href=#main-menu-toggle role=button id=main-menu-close class=menu-close aria-expanded=false aria-controls=main-menu aria-label="Close main menu"><span class=sr-only>Close main menu</span>
<span aria-hidden=true><i class="fas fa-window-close"></i></span></a><ul><li><a href=https://bdcaf.github.io/#about><span>About</span></a></li><li><a href=https://bdcaf.github.io/#posts><span>Posts</span></a></li><li><a href=https://bdcaf.github.io/#publications_selected><span>Publications</span></a></li><li><a href=https://bdcaf.github.io/#projects><span>Projects</span></a></li><li><a href=https://bdcaf.github.io/#contact><span>Contact</span></a></li></ul></nav><a href=#main-menu-toggle class=backdrop tabindex=-1 aria-hidden=true hidden></a></div></header><div class=content><div class=pub itemscope itemtype=http://schema.org/CreativeWork><div class=pub-title><h1 itemprop=name>Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.</h1><span class=pub-authors itemprop=author>Wojciech Filipiak, Andreas Sponring, Maria Magdalena Baur, Anna Filipiak, Clemens Ager, Helmut Wiesenhofer, Markus Nagl, Jakob Troppmair and Anton Amann</span>
<span class=pull-right></span></div><div class=article-container><h3>Abstract</h3><p class=pub-abstract>BACKGROUND: The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to develop a non-invasive method for the early detection of bacterial infection in ventilated patients, preferably allowing the identification of the specific pathogens. The present work is an attempt to identify pathogen-derived volatile biomarkers in breath that can be used for early and non-invasive diagnosis of ventilator associated pneumonia (VAP). For this purpose, in vitro experiments with bacteria most frequently found in VAP patients, i.e. Staphylococcus aureus and Pseudomonas aeruginosa, were performed to investigate the release or consumption of volatile organic compounds (VOCs). RESULTS: Headspace samples were collected and preconcentrated on multibed sorption tubes at different time points and subsequently analyzed with gas chromatography mass spectrometry (GC-MS). As many as 32 and 37 volatile metabolites were released by S. aureus and P. aeruginosa, respectively. Distinct differences in the bacteria-specific VOC profiles were found, especially with regard to aldehydes (e.g. acetaldehyde, 3-methylbutanal), which were taken up only by P. aeruginosa but released by S. aureus. Differences in concentration profiles were also found for acids (e.g. isovaleric acid), ketones (e.g. acetoin, 2-nonanone), hydrocarbons (e.g. 2-butene, 1,10-undecadiene), alcohols (e.g. 2-methyl-1-propanol, 2-butanol), esters (e.g. ethyl formate, methyl 2-methylbutyrate), volatile sulfur compounds (VSCs, e.g. dimethylsulfide) and volatile nitrogen compounds (VNCs, e.g. 3-methylpyrrole). Importantly, a significant VOC release was found already 1.5 hours after culture start, corresponding to cell numbers of ~8*106 [CFUs/ml]. CONCLUSIONS: The results obtained provide strong evidence that the detection and perhaps even identification of bacteria could be achieved by determination of characteristic volatile metabolites, supporting the clinical use of breath-gas analysis as non-invasive method for early detection of bacterial lung infections.</p><div class=pub-attrib><h4>Publication</h4><div>BMC microbiology,
<i>12</i>(1),113</div><h4>Identifier</h4><div><a href=https://doi.org/10.1186/1471-2180-12-113><span>DOI:&nbsp;10.1186/1471-2180-12-113</span></a>
<span>ISBN:&nbsp;1471218012113</span><span> PMID:&nbsp;22716902</span></div><h4>Date</h4><div itemprop=datePublished>January, 2012</div><h4>Links</h4><div><a href=https://www.ncbi.nlm.nih.gov/pubmed/22716902>PDF</a></div><div class=article-style></div></div></div></div></div><footer><p class=powered-by>Clemens Ager, Brixlegg &middot;Powered by <a href=http://gohugo.io target=_blank>Hugo</a>.
&middot;
<a href=https://bdcaf.github.io/index.xml>RSS <i class="fas fa-rss-square"></i></a></p></footer></body></html>